SMPD1 and schizophrenia: In addition to the effects of sphingomyelin and ceramide on presynaptic DA release, the ASM-ceramide system may promote neuroinflammation through cytokine release, microglial activation, and other immune processes that have been demonstrated in schizophrenia [48–51] (Fig. 2).